Thymidylate Synthase Levels and Chemotherapy Response in Colorectal Cancer
Author Information
Author(s): MPN Findlay, D Cunningham, G Morgan, S Clinton, A Hardcastle, GW Aherne
Primary Institution: Royal Marsden Hospital
Hypothesis
Does thymidylate synthase expression in primary colorectal tumors correlate with response to chemotherapy?
Conclusion
The study found no correlation between thymidylate synthase levels in primary colorectal tumors and the response to chemotherapy.
Supporting Evidence
- Thymidylate synthase levels varied widely in tumor samples but did not predict chemotherapy response.
- Patients with higher TS levels did not show better outcomes in terms of survival or response to treatment.
- Previous studies suggested a link between TS levels and chemotherapy resistance, but this study found no such correlation.
Takeaway
The amount of a certain protein in colorectal cancer tumors doesn't help doctors predict how well chemotherapy will work.
Methodology
The study used immunohistochemical methods to measure thymidylate synthase levels in tumor samples and compared these levels with clinical outcomes.
Limitations
The study only included patients needing palliative chemotherapy, which may not represent the broader population of colorectal cancer patients.
Participant Demographics
{"median_age":62,"gender_ratio":"84:50 (M:F)"}
Want to read the original?
Access the complete publication on the publisher's website